| | Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-|化合物NHWD-870 基本信息 更多信息 |
| 中文名称: | 化合物NHWD-870 | | 中文同义词: | 化合物NHWD-870;(S)-7-(1,4-二甲基-1H-1,2,3-三唑-5-基)-1-甲基-9-(苯基(四氢-2H-吡喃-4-基)甲基)-1,9-二氢吡啶并[2',3':4,5]吡咯并[3,2-F]吲唑;(S)-7-(1,4-二甲基-1H-1,2,3-三唑-5-基)-1-甲基-9-(苯基(四氢-2H-吡喃-4-基)甲基)-1,9-二氢吡啶并[2',3':4,5]吡咯并[3,2-F]吲唑 | | 英文名称: | Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]- | | 英文同义词: | Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-;NHWD-870;NHWD 870,melanoma,cell-macrophage,bromodomains,Inhibitor,inhibit,oral,Epigenetic Reader Domain,selective,Apoptosis,NHWD-870,NHWD870,cancer,interaction;(S)-7-(1,4-Dimethyl-1H-1,2,3-triazol-5-yl)-1-methyl-9-(phenyl(tetrahydro-2H-pyran-4-yl)methyl)-1,9-dihydropyrido[2',3':4,5]pyrrolo[3,2-f]indazole;(S)-7-(1,4-Dimethyl-1H-1,2,3-triazol-5-yl)-1-methyl-9-(phenyl(tetrahydro-2H-pyran-4-yl)methyl)-1,9-dihydropyrido[2',3':4,5]pyrrolo[3,2-f]indazole | | CAS号: | 2115742-03-3 | | 分子式: | C29H29N7O | | 分子量: | 491.59 | | EINECS号: | | ![Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-|化合物NHWD-870](/CAS/20210111/GIF/2115742-03-3.gif) |
|
| 按国家浏览Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-国外供应商 |
中国供应商 |
|
Pyrido[2',3':4,5]pyrrolo[3,2-f]indazole, 7-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-1,9-dihydro-1-methyl-9-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]- 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|